Grant: Discovery Grants Program - Individual
University of Alberta
$31,000.00
Cholesterol homeostasis and pancreatic beta cell function
FY 2018-19
Summary
Blood glucose is physiologically important since it is an energy source and the starting material for many biosynthesis as well. However, prolonged high blood glucose levels are detrimental, causing damages to immune system, nerves, etc. Thus, blood glucose homeostasis is strictly regulated, in which pancreatic beta cells play an essential role via producing and secreting insulin. Cholesterol, an essential component of cell membranes, is important for beta cell function. Disruption of cholesterol homeostasis causes beta cell dysfunction, leading to insulin deficiency. Beta cell cholesterol homeostasis is regulated by de novo biosynthesis, uptake and efflux. 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) is the rate-limiting enzyme in cholesterol biosynthesis pathway. Low-density lipoprotein receptor (LDLR)-mediated LDL uptake is the main pathway for cholesterol uptake. Cellular cholesterol efflux mainly depends on ATP-binding cassette transporters A1 and G1 (ABCA1 and ABCG1)-mediated cholesterol translocation. In addition, proprotein convertase subtilisin/kexin type 9 (PCSK9) and Niemann-Pick disease type C1 (NPC1) regulate cholesterol metabolism via promoting LDLR degradation and facilitating export of cholesterol from the lysosome, respectively. Sterol regulatory element-binding protein 2 (SREBP2) is the master regulator of cholesterol homeostasis via upregulating transcription of LDLR, HMGCR, PCSK9, and SREBP2. In addition, intron 16 of SREBP2 contains miR33 that targets ABCA1 and NPC1. *Currently, our understanding of the roles of PCSK9 and NPC1 in beta cell function is limited. Given the contributions of PCSK9 and NPC1 to maintaining cellular cholesterol homeostasis and the role of cholesterol in beta cell function, we hypothesize that PCSK9 and NPC1 are critical for beta cell function. The long-term objective of this program is to obtain a better fundamental understanding of how cholesterol homeostasis is regulated in beta cells. Short-term objectives are to determine if and how PCSK9 and NPC1 affect beta cell cholesterol homeostasis and function including (A) insulin secretion, (B) cholesterol trafficking, (C) cholesterol uptake and efflux, and (D) expression of genes encoding proteins important for cholesterol metabolism.*Human primary beta cells will be used as a working model since cholesterol metabolism is different between mouse and human cells. Gene knockdown and pharmaceutical inhibition will be used to manipulate expression of target genes.*This research will provide fundamental knowledge on whether and how different pathways regulate beta cell cholesterol homeostasis and function. Outcome may provide novel approaches to treat defective plasma glucose homeostasis. Furthermore, it will provide elite training for students with a wide range of expertise and techniques in biochemistry, molecular and cell biology.*
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2016-06479
Name nom
Zhang, Dawei
Department département
Pediatrics
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2016
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5405
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Lipids
Research subject fr
Lipides
Partie
3
Nb partie
5
Application title
Cholesterol homeostasis and pancreatic beta cell function
Keyword
NSERC
Application summary
Blood glucose is physiologically important since it is an energy source and the starting material for many biosynthesis as well. However, prolonged high blood glucose levels are detrimental, causing damages to immune system, nerves, etc. Thus, blood glucose homeostasis is strictly regulated, in which pancreatic beta cells play an essential role via producing and secreting insulin. Cholesterol, an essential component of cell membranes, is important for beta cell function. Disruption of cholesterol homeostasis causes beta cell dysfunction, leading to insulin deficiency. Beta cell cholesterol homeostasis is regulated by de novo biosynthesis, uptake and efflux. 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) is the rate-limiting enzyme in cholesterol biosynthesis pathway. Low-density lipoprotein receptor (LDLR)-mediated LDL uptake is the main pathway for cholesterol uptake. Cellular cholesterol efflux mainly depends on ATP-binding cassette transporters A1 and G1 (ABCA1 and ABCG1)-mediated cholesterol translocation. In addition, proprotein convertase subtilisin/kexin type 9 (PCSK9) and Niemann-Pick disease type C1 (NPC1) regulate cholesterol metabolism via promoting LDLR degradation and facilitating export of cholesterol from the lysosome, respectively. Sterol regulatory element-binding protein 2 (SREBP2) is the master regulator of cholesterol homeostasis via upregulating transcription of LDLR, HMGCR, PCSK9, and SREBP2. In addition, intron 16 of SREBP2 contains miR33 that targets ABCA1 and NPC1. *Currently, our understanding of the roles of PCSK9 and NPC1 in beta cell function is limited. Given the contributions of PCSK9 and NPC1 to maintaining cellular cholesterol homeostasis and the role of cholesterol in beta cell function, we hypothesize that PCSK9 and NPC1 are critical for beta cell function. The long-term objective of this program is to obtain a better fundamental understanding of how cholesterol homeostasis is regulated in beta cells. Short-term objectives are to determine if and how PCSK9 and NPC1 affect beta cell cholesterol homeostasis and function including (A) insulin secretion, (B) cholesterol trafficking, (C) cholesterol uptake and efflux, and (D) expression of genes encoding proteins important for cholesterol metabolism.*Human primary beta cells will be used as a working model since cholesterol metabolism is different between mouse and human cells. Gene knockdown and pharmaceutical inhibition will be used to manipulate expression of target genes.*This research will provide fundamental knowledge on whether and how different pathways regulate beta cell cholesterol homeostasis and function. Outcome may provide novel approaches to treat defective plasma glucose homeostasis. Furthermore, it will provide elite training for students with a wide range of expertise and techniques in biochemistry, molecular and cell biology.*